m+Medelevator.RU
← Поиск публикаций
Shock (Augusta, Ga.) · 2026

Temporal changes of the von Willebrand factor-ADAMTS13 axis during the first 24 hours in major trauma patients with isolated brain injury and without brain injury: a prospective observational study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Verdonck Philip, Janssens Eva, Van Laer Kirsten, Vangenechten Inge, Snijders Erwin, Sypré Lore, Lemoyne Sabine, Jorens Philippe, Schnaubelt Sebastian, Roelant Ella, Gadisseur Alain, Monsieurs Koenraad

Аннотация

BACKGROUND: Dysregulation of the VWF-ADAMTS13 (von Willebrand factor-a disintegrin and metalloprotease with thrombospondin type 1 motif, member 13) axis contributes to trauma-induced coagulopathy (TIC) and adverse outcomes after trauma. Whether this dysregulation is injury-specific remains unclear. We investigated early and temporal changes in the VWF-ADAMTS13 axis in isolated trauma brain injury (iTBI) patients versus non-TBI trauma patients.

MATERIAL AND METHODS: In a prospective observational cohort study, 50 iTBI patients and 50 non-TBI trauma patients were recruited at Antwerp University Hospital (June 2023-January 2025). VWF antigen (VWF:Ag), VWF collagen binding activity (VWF:CBA), VWF platelet GPIb binding activity (VWF:GPIb), VWF multimers, ADAMTS13 antigen (ADAMTS13:Ag), ADAMTS13 activity (ADAMTS13:Ac), factor VIII coagulant activity (FVIII:C), and activated protein C (aPC) were measured at admission (TED) and at 24 hours (T24). Linear mixed-effects models assessed time- and group-dependent changes.

RESULTS: In non-TBI patients, VWF:Ag, VWF:CBA, and VWF:GPIb decreased from TED to T24 by 51.33 IU/dL (95% CI: -70.12, -32.54; p < 0.001), 51.08 IU/dL (95% CI: -77.38, -24.77; p < 0.001), and 65.52 IU/dL (95% CI: -94.50, -36.55; p < 0.001), respectively. No such changes were observed in iTBI patients. The ADAMTS13:Ac/VWF:Ag ratio was 34% higher at TED in iTBI patients compared to non-TBI patients (1.34 [95% CI: 1.07-1.68]; p = 0.01) and decreased by 23% from TED to T24 exclusively in iTBI patients (0.77 [95% CI: 0.67-0.88]; p < 0.001). Temporal changes were similar between groups for the remaining parameters: ADAMTS13:Ag decreased by 11.44 IU/dL (95% CI: -15.93, -6.95; p < 0.001), ADAMTS13:Ac by 14.26 IU/dL (95% CI: -18.06, -10.45; p < 0.001), and FVIII:C by 73.06 IU/dL (95% CI: -94.50, -51.62; p < 0.001). The aPC ratio increased by 0.07 (95% CI: 0.05, 0.10; p < 0.001).

CONCLUSION: Temporal changes of the VWF-ADAMTS13 axis differ between iTBI and non-TBI trauma patients within the first 24 hours after injury, suggesting injury-specific regulation of coagulation and endothelial responses that may support personalized coagulation strategies.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты